Clinical Trials Browser

cMET Dysegulation Advanced Solid Tumors × capmatinib × Clear all

NCT02925104 2020-12-19

A Dose Escalation Study to Assess PK, Safety and Tolerability of INC280 When Taken With Food in cMET Dysregulated Advanced Solid Tumors.

Phase 1 Completed

Other solid neoplasm

cMET Dysegulation Advanced Solid Tumors